Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase EARLY_PHASE1 × Completed × cediranib × Clear all

Phase

Phase 2 26 Phase 1 20 Phase 2/3 3 Phase 1/2 3 Phase 3 2 Phase NA 1 Phase EARLY_PHASE1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 21 Metformin 13 pembrolizumab 10 Biopsy 10 Radiotherapy 7 Cyclophosphamide 7 Sirolimus 6 Nivolumab 6 Bevacizumab 6 gallium 68 PSMA-11 5 Rituximab 5 Granulocyte Colony-Stimulating Factor 5 Fluorouracil 5 Etoposide 5 Radiosurgery 4 Radiation 4 Methotrexate 4 Fluorodeoxyglucose F18 4 Filgrastim 4 Doxorubicin 4 Cisplatin 4 Aspirin 4 poly ICLC 3 olaparib 3 fluciclovine F-18 3 durvalumab 3 Vitamin D 3 Vincristine 3 Valproic Acid 3 Temozolomide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02855697 2022-02-22

MOLTO

The Christie NHS Foundation Trust

Phase EARLY_PHASE1 Completed

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡